New Ajax Health Affiliate Raises $90 Million Led by KKR, Hellman

Ajax Health has established a new medical technology company to develop a treatment for the most common heart rhythm disorder.

The new company, Cortex, has raised $90 million from KKR & Co. and Hellman & Friedman, according to a statement reviewed by Bloomberg News. Cortex is developing an integrated, comprehensive platform for evaluating and treating atrial fibrillation.

KKR and Hellman & Friedman are investing in Cortex through the Cordis accelerator, Cordis-X, according to the statement. KKR is investing additional capital in Cortex through its Health Care Strategic Growth Fund II.

Based in Menlo Park, California, Ajax Health helps build ...